UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple chemo cocktail shows promise for tough biliary cancers
Disease control CompletedThis study tested whether adding a third chemotherapy drug (nab-paclitaxel) to the standard two-drug treatment helps people with advanced bile duct or gallbladder cancer live longer. 452 adults with newly diagnosed, advanced disease took part. The goal was to see if the three-dru…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Promising combo tackles tough liver cancer in small trial
Disease control CompletedThis study tested a combination of two drugs (durvalumab and SNDX-6352) in 5 adults with a type of liver cancer that cannot be surgically removed. The goal was to see if the combo could shrink tumors or slow the cancer after standard liver-directed treatments. The trial focused o…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 15, 2026 11:55 UTC